Abid Ur Rahman: Understanding the Coagulation Cascade and Hemostasis
Abid Ur Rahman, Laboratory Intern at Islamabad Diagnostic Centre, shared a post on LinkedIn:
“Coagulation Cascade Simplified
The coagulation cascade is a complex series of enzymatic reactions that leads to the formation of a stable blood clot to prevent excessive bleeding after vascular injury.
It involves intrinsic, extrinsic, and common pathways, ultimately producing fibrin, which stabilizes the platelet plug.
Phases of Hemostasis
1.Vasoconstriction
- Immediate narrowing of blood vessels after injury
- Reduces blood loss
2.Primary Hemostasis
- Platelets adhere and aggregate at injury site
- Forms temporary platelet plug
3.Secondary Hemostasis (Coagulation Cascade)
- Activation of clotting factors
- Formation of fibrin clot
Extrinsic Pathway (Fast Pathway)
Initiated by tissue injury
Key Factor:
Factor VII (7) and Tissue Factor (Factor III)
Features:
- Rapid activation
- Evaluated by Prothrombin Time (PT/INR)
Pathway:
Tissue injury leads to Tissue Factor exposure, which activates Factor VII, resulting in Factor X activation.
Intrinsic Pathway (Slow Pathway)
Activated by damage within blood vessels
Key Factors:
Factor XII, Factor XI, Factor IX, and Factor VIII
Features:
- Slower but amplifies coagulation
- Evaluated by Activated Partial Thromboplastin Time (APTT)
Pathway:
Activation of Factor XII leads to activation of Factor XI, followed by activation of Factor IX together with Factor VIII, ultimately resulting in Factor X activation.
Common Pathway
Both intrinsic and extrinsic pathways merge here.
Key Factors:
Factor X, Factor V, Prothrombin, and Fibrinogen
Steps:
- Factor X converts Prothrombin into Thrombin
- Thrombin converts Fibrinogen into Fibrin
- Factor XIII stabilizes fibrin clot
Final Result:
Stable fibrin clot formation
Important Clotting Factors
Factor Name
- I Fibrinogen
- II Prothrombin
- III Tissue Factor
- IV Calcium
- VIII Anti-hemophilic factor A
- IX Christmas factor
- X Stuart-Prower factor
Natural Anticoagulants
- Antithrombin
- Protein C and Protein S
- Tissue Factor Pathway Inhibitor (TFPI)
Prevent excessive clot formation
Laboratory Tests Associated
- PT / INR evaluates Extrinsic pathway
- APTT evaluates Intrinsic pathway
- D-dimer reflects Fibrin degradation
- Fibrinogen assay assesses Clotting ability
Clinical Importance
Disorders of coagulation may lead to:
- Excessive bleeding (Hemophilia, DIC)
- Thrombosis (DVT, PE)
- Liver disease-related coagulopathy
- Vitamin K deficiency
Understanding the cascade is essential for interpreting coagulation tests and anticoagulant therapy.
The coagulation cascade transforms vascular injury into controlled clot formation, maintaining the balance between bleeding and thrombosis.”
Stay updated with Hemostasis Today.
-
May 26, 2026, 11:35Isaac Okello: The Real Sickle Cell Crisis Is Not Only the Disease Itself
-
May 26, 2026, 11:34Ziad Omar: PTT / aPTT Test – Reading the Intristic Pathway of Coagulation
-
May 26, 2026, 11:33Megan Griffiths: Advancing the Understanding of Risk and Outcomes in Pulmonary Hypertension
-
May 26, 2026, 11:30Samantha Pasca: How Should We Manage Cardiovascular Disease in Patients With Hemophilia?
-
May 26, 2026, 11:05Hassan Raza։ When the Platelet Count Lies – Think Artifact Before Disease
-
May 26, 2026, 10:26Gestur Vidarsson: Could Antibody Fucosylation Help Predict FNAIT Severity
-
May 26, 2026, 10:17Alan Nurden: New Review Highlights the Importance of Mitochondria in Platelet Function
-
May 26, 2026, 10:12Zoe Cahill: Are We Designing Vascular Grafts for Structure Instead of Biology
-
May 26, 2026, 10:04Dima Shulkin: A Novel Monocyte-Based Biomarker of Cardiovascular Risk